Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya | MicrobiomeTrials← Back to trialsNCT05498727
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya
CompletedOBSERVATIONAL
Trial Details
Start: 2022-05-02Est. Completion: 2022-10-31
Enrollment target: 527,184 participants Locations- Health facilities in Cameroon, Yaoundé, Cameroon
- Health facilities in Kenya, Nairobi, Kenya
Other microbiome trials you might be interested in
FibromyalgiaFibromyalgia, Primary
This study is a randomized, single-blinded, parallel, superiority, controlled trial. The main objective is to verify the…
Pelotas, BrazilCompleted Jan 7, 2022
Chronic Kidney Disease Stage 5End Stage Renal Disease
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care wi…
Winnipeg, CanadaEst. completion Mar 30, 2027
Recruiting
Total knee replacement (TKR) is a successful and cost-effective treatment for end-stage arthritis. Its usage is increasi…
Leeds, United KingdomEst. completion Sep 1, 2026